GHK-Cu dosing claims on TikTok: what the research actually supports

What did @thaideutsche actually say?

Honestly? Not much that's usable. The transcript is largely incoherent, containing phrases like "you're not going to use Flipk dick on the landing" and "I'm gonna leave you with a few more words." The video is captioned as a response about GHK-Cu dosing, but the transcript as captured contains no legible dosing information, no mechanism claims, and no sourced statements. This makes a standard fact-check nearly impossible to perform on the actual spoken content.

The hashtag category places this in peptide therapy territory, specifically GHK-Cu (copper peptide GHK-Cu), which is used in skincare and increasingly discussed in longevity circles. But if dosing guidance was given, it either wasn't captured properly or was delivered in a language mix that the transcription tool couldn't parse. The creator appears to be German-Thai based on the handle, so a multilingual delivery may explain some of the transcript noise.

Does the science back this up?

We can't evaluate what wasn't clearly stated. What we can do is assess the state of GHK-Cu research, since that's the stated subject. The short answer: the topical evidence is reasonably solid, the systemic evidence is not.

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) has been studied primarily in wound healing and skin biology. Pickart and Margolina (2018, Cosmetics) reviewed decades of GHK research and found consistent evidence for collagen synthesis stimulation, antioxidant activity, and anti-inflammatory signaling in cell and animal studies. Importantly, these were largely in vitro or rodent findings. Human clinical trials on systemic GHK-Cu administration are thin. A 2012 paper by Pickart et al. in the same journal noted improvements in skin laxity and wrinkle reduction in small topical trials, but sample sizes were small and industry-adjacent.

For injectable or intranasal GHK-Cu, which is what peptide communities typically discuss when talking about "dosing," there is essentially no robust human trial data. The pharmacokinetics in humans after subcutaneous injection are not well characterized in peer-reviewed literature.

What did they get wrong (or right)?

We cannot credit or critique specific claims that weren't legibly transcribed. That itself is a problem worth naming: a video with 5,300 views purportedly giving dosing guidance on a bioactive peptide should be clear enough to understand. Dosing information for compounds like GHK-Cu, which is sold as a research chemical in many markets and is not FDA-approved for systemic use, carries real risk if misheard or misapplied.

What we can say is this: any GHK-Cu dosing claim made to a general TikTok audience, without clinical context, is operating well outside what the evidence supports. There is no established safe dosing range for injectable GHK-Cu in humans published in peer-reviewed literature. Anyone presenting specific numbers as settled fact is going beyond what the data shows. That's true regardless of whether this creator did so, because the transcript doesn't confirm it either way.

What should you actually know?

GHK-Cu is a naturally occurring tripeptide found in human plasma, saliva, and urine. Concentrations decline with age, which is one reason longevity researchers have shown interest in it. Pickart (2008, Rejuvenation Research) described it as a "potent tissue repair and anti-inflammatory agent" based on animal models, but that description has been stretched considerably by supplement and peptide marketers.

Topical GHK-Cu products are legal, widely available, and have the most evidence behind them, though even that evidence is not FDA-reviewed for efficacy claims. Injectable forms exist in gray-market peptide supply chains. These are not approved drugs, not manufactured under pharmaceutical-grade oversight in most cases, and carry contamination and dosing accuracy risks that topical products do not.

If you encountered this video looking for actual dosing guidance, stop there. No TikTok video, including this one, is a substitute for working with a clinician who can assess your individual situation, review your bloodwork, and take responsibility for a treatment plan.

The bottom line on this video

The transcript is too degraded to fact-check substantive claims. The category and caption suggest GHK-Cu dosing was discussed, but nothing in the captured text can be verified or refuted with confidence. The most accurate thing we can say is that systemic GHK-Cu dosing guidance from social media, from anyone, is ahead of the clinical evidence. Proceed with skepticism.